Preclinical Evaluation of a Novel SIRT1 Modulator SRT1720 in Multiple Myeloma Cells

Lignende værker

• A novel vascular disrupting agent plinabulin triggers JNK-mediated apoptosis and inhibits angiogenesis in multiple myeloma cells
  af: Singh, Ajita V., et al.
  Udgivet: (2011)
• A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma
  af: Chauhan, Dharminder, et al.
  Udgivet: (2010)
• PR-924, a Selective Inhibitor of the Immunoproteasome Subunit LMP-7, Blocks Multiple Myeloma Cell Growth both in Vitro and in Vivo
  af: Singh, Ajita V., et al.
  Udgivet: (2010)
• Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma
  af: Ray, Arghya, et al.
  Udgivet: (2020)
• SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
  af: Pacholec, Michelle, et al.
  Udgivet: (2010)